← FDA DRUG APPROVALS

FDA ANDA · ANDA072065

IBUPROFEN

Sponsor: SANDOZ

APPLICATION
ANDA072065
TYPE
ANDA
ORIGINAL APPROVAL
1988-01-14
LATEST ACTION
1997-05-21
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

IBUPROFENDiscontinued
IBUPROFEN 600MG · TABLET · ORAL

Approval history

1997-05-21Labeling · Supplement 9AP
1991-02-20Labeling · Supplement 8AP
1989-04-12Labeling · Supplement 6AP
1988-01-14OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →